Upgrades
Arthur J. Gallagher & Co. (NYSE:AJG) was upgraded by research analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a research report issued to clients and investors on Monday, The Fly reports.
Other equities analysts have also recently issued research
reports about the company. UBS Group started coverage on Arthur J. Gallagher
& Co. in a report on Monday, April 18th. They issued a “neutral” rating and
a $192.00 target price for the company. William Blair reiterated an
“outperform” rating on shares of Arthur J. Gallagher & Co. in a research
report on Thursday, January 27th. Wells Fargo & Company upped their price
target on Arthur J. Gallagher & Co. from $193.00 to $209.00 and gave the
company an “overweight” rating in a research report on Tuesday, April 12th.
Royal Bank of Canada cut their target price on Arthur J. Gallagher & Co.
from $170.00 to $160.00 in a research report on Friday, January 28th. Finally,
Zacks Investment Research upgraded Arthur J. Gallagher & Co. from a “hold”
rating to a “strong-buy” rating and set a $191.00 price target on the stock in
a report on Friday, March 25th. One research analyst has rated the stock with a
sell rating, six have assigned a hold rating, seven have assigned a buy rating
and two have issued a strong buy rating to the stock. According to
MarketBeat.com, Arthur J. Gallagher & Co. currently has an average rating
of “Buy” and a consensus price target of $173.59. Read more ...
JPMorgan Chase & Co. upgraded shares of SJW Group (NYSE:SJW) from a neutral rating to an overweight rating in a report published on Monday morning, The Fly reports. The firm currently has $67.00 price objective on the utilities provider’s stock.
A number of other equities research analysts have also
recently commented on the company. StockNews.com initiated coverage on SJW
Group in a report on Thursday, March 31st. They set a hold rating on the stock.
Barclays increased their target price on SJW Group from $70.00 to $73.00 and
gave the company an equal weight rating in a report on Tuesday, March 15th.
Zacks Investment Research cut SJW Group from a hold rating to a sell rating in
a report on Wednesday, March 30th. Finally, Seaport Res Ptn upgraded SJW Group
from a neutral rating to a buy rating in a report on Tuesday, January 25th. One
equities research analyst has rated the stock with a sell rating, two have
issued a hold rating and three have given a buy rating to the stock. According
to MarketBeat, the stock has an average rating of Hold and a consensus target
price of $72.50. Read more ...
JPMorgan Chase & Co. (NYSE:JPM) was upgraded by investment analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a report released on Tuesday, The Fly reports.
A number of other research analysts also recently weighed in
on the stock. Zacks Investment Research upgraded shares of JPMorgan Chase &
Co. from a “sell” rating to a “hold” rating and set a $147.00 price target on
the stock in a report on Monday, March 21st. Morgan Stanley reduced their price
target on JPMorgan Chase & Co. from $170.00 to $161.00 and set an
“underweight” rating for the company in a research report on Monday, March
28th. Barclays set a $200.00 price target on JPMorgan Chase & Co. in a
research note on Wednesday, April 6th. Argus decreased their price target on
JPMorgan Chase & Co. from $177.00 to $155.00 in a research note on
Thursday, April 14th. Finally, Keefe, Bruyette & Woods decreased their
price target on JPMorgan Chase & Co. from $166.00 to $157.00 and set a
“market perform” rating for the company in a research note on Monday, January
17th. One investment analyst has rated the stock with a sell rating, eleven
have assigned a hold rating and seven have assigned a buy rating to the stock.
Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a
consensus price target of $163.72. Read more ...
Linde (NYSE:LIN) was upgraded by equities researchers at AlphaValue to a "reduce" rating in a report issued on Tuesday, The Fly reports.
Other equities analysts also recently issued research
reports about the stock. BMO Capital Markets cut their price target on shares
of Linde from $405.00 to $365.00 and set an "outperform" rating on
the stock in a report on Monday, February 14th. Citigroup increased their price
target on shares of Linde from $381.00 to $400.00 in a report on Tuesday,
January 11th. Jefferies Financial Group started coverage on shares of Linde in
a research note on Wednesday, March 30th. They set a "buy" rating and
a $390.00 price objective on the stock. Morgan Stanley raised their price
objective on shares of Linde from $330.00 to $365.00 and gave the stock an
"overweight" rating in a research note on Tuesday, January 11th.
Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating
and set a $352.00 price objective on shares of Linde in a research note on
Friday. One research analyst has rated the stock with a sell rating, four have
given a hold rating and sixteen have issued a buy rating to the company's
stock. According to MarketBeat, the company currently has an average rating of
"Buy" and a consensus target price of $360.47. Read more ...
Morgan Stanley (NYSE:MS) was upgraded by Oppenheimer from a “market perform” rating to an “outperform” rating in a research report issued on Tuesday, The Fly reports.
MS has been the subject of a number of other research
reports. UBS Group raised their target price on shares of Morgan Stanley from
$119.00 to $125.00 and gave the company a “buy” rating in a research report on
Tuesday, January 4th. BMO Capital Markets raised their target price on shares
of Morgan Stanley from $110.00 to $113.00 and gave the company an “outperform”
rating in a research report on Monday, April 18th. The Goldman Sachs Group set
a $105.00 price target on shares of Morgan Stanley in a research note on
Wednesday, April 20th. Wells Fargo & Company cut their price target on
shares of Morgan Stanley from $104.00 to $94.00 and set an “equal weight”
rating for the company in a research note on Monday, April 4th. Finally, Zacks
Investment Research cut shares of Morgan Stanley from a “buy” rating to a
“hold” rating and set a $91.00 price target for the company. in a research note
on Wednesday, March 16th. Twelve analysts have rated the stock with a hold
rating and eleven have assigned a buy rating to the stock. According to data
from MarketBeat, the stock has an average rating of “Hold” and an average
target price of $106.71. Read more ...
Starbucks (NASDAQ:SBUX) was upgraded by investment analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports. The brokerage presently has a $95.00 target price on the coffee company’s stock. Evercore ISI’s target price would indicate a potential upside of 22.61% from the company’s previous close.
SBUX has been the subject of several other reports. UBS
Group lowered their price objective on Starbucks from $105.00 to $86.00 and set
a “neutral” rating for the company in a research report on Monday, April 25th.
The Goldman Sachs Group cut Starbucks from a “buy” rating to a “neutral” rating
and reduced their price objective for the company from $112.00 to $106.00 in a
research note on Wednesday, February 2nd. Citigroup cut Starbucks from a “buy”
rating to a “neutral” rating and reduced their price objective for the company
from $120.00 to $91.00 in a research note on Monday, April 11th. MKM Partners
cut their price target on Starbucks from $115.00 to $105.00 and set a “buy”
rating on the stock in a research note on Wednesday, April 20th. Finally,
Robert W. Baird cut their price target on Starbucks from $95.00 to $85.00 in a
research note on Monday, April 25th. One analyst has rated the stock with a
sell rating, thirteen have given a hold rating and fourteen have issued a buy
rating to the company’s stock. According to MarketBeat, the stock currently has
a consensus rating of “Hold” and a consensus target price of $102.46. Read more ...
Scotts Miracle-Gro (NYSE:SMG) was upgraded by research analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a report released on Wednesday, The Fly reports. The analysts noted that the move was a valuation call.
Other research analysts also recently issued research
reports about the company. Barclays downgraded Scotts Miracle-Gro from an
“overweight” rating to an “equal weight” rating and lowered their target price
for the company from $150.00 to $110.00 in a report on Thursday, April 21st.
Wells Fargo & Company reduced their price target on Scotts Miracle-Gro from
$170.00 to $160.00 and set an “overweight” rating for the company in a research
report on Thursday, March 17th. Truist Financial reduced their price target on
Scotts Miracle-Gro from $225.00 to $185.00 in a research report on Tuesday,
March 22nd. Zacks Investment Research upgraded Scotts Miracle-Gro from a “sell”
rating to a “hold” rating and set a $123.00 price target for the company in a
research report on Tuesday, April 12th. Finally, Raymond James reduced their
price target on Scotts Miracle-Gro from $185.00 to $150.00 and set a
“strong-buy” rating for the company in a research report on Monday, March 14th.
One equities research analyst has rated the stock with a sell rating, three
have assigned a hold rating, five have given a buy rating and one has given a
strong buy rating to the stock. According to data from MarketBeat.com, the
company currently has a consensus rating of “Buy” and an average price target
of $180.89. Read more ...
Downgrades
KeyCorp (NYSE:KEY) was downgraded by equities research analysts at Piper Sandler from a “neutral” rating to an “underweight” rating in a research report issued on Monday, MarketBeat reports. They presently have a $20.50 price objective on the financial services provider’s stock, down from their previous price objective of $23.00. Piper Sandler’s price objective would suggest a potential upside of 4.01% from the company’s previous close.
A number of other research firms have also recently issued
reports on KEY. Odeon Capital Group cut KeyCorp from a “buy” rating to a “hold”
rating in a report on Tuesday, April 26th. Citigroup reiterated a “neutral”
rating on shares of KeyCorp in a report on Thursday, March 24th. Jefferies
Financial Group cut KeyCorp from a “buy” rating to a “hold” rating in a report
on Monday, April 11th. Morgan Stanley cut their price objective on KeyCorp from
$30.00 to $27.00 and set an “equal weight” rating for the company in a report
on Monday, March 28th. Finally, Barclays upped their price objective on KeyCorp
from $24.00 to $26.00 in a report on Monday, January 3rd. One investment
analyst has rated the stock with a sell rating, six have assigned a hold
rating, eight have issued a buy rating and one has assigned a strong buy rating
to the company’s stock. Based on data from MarketBeat, the company has a
consensus rating of “Buy” and an average target price of $26.83. Read more ...
Amgen (NASDAQ:AMGN) was downgraded by research analysts at Oppenheimer to an “outperform” rating in a report released on Tuesday. They currently have a $285.00 target price on the medical research company’s stock. Oppenheimer’s target price would indicate a potential upside of 20.71% from the stock’s previous close. Oppenheimer also issued estimates for Amgen’s FY2022 earnings at $17.12 EPS, FY2023 earnings at $18.92 EPS, FY2024 earnings at $21.17 EPS, FY2025 earnings at $23.40 EPS and FY2026 earnings at $25.84 EPS.
Several other research analysts have also issued reports on
the stock. Jefferies Financial Group lifted their price target on shares of
Amgen from $266.00 to $280.00 and gave the stock a “buy” rating in a research
report on Wednesday, February 9th. Wells Fargo & Company raised their price
objective on shares of Amgen from $210.00 to $250.00 and gave the stock an
“equal weight” rating in a research note on Wednesday, February 9th. Barclays
raised their price objective on shares of Amgen from $233.00 to $236.00 and gave
the stock an “equal weight” rating in a research note on Tuesday, April 12th.
TheStreet lowered shares of Amgen from a “b+” rating to a “c+” rating in a
research note on Wednesday, April 27th. Finally, StockNews.com lowered shares
of Amgen from a “strong-buy” rating to a “buy” rating in a research note on
Tuesday, April 5th. One analyst has rated the stock with a sell rating, eleven
have given a hold rating and four have assigned a buy rating to the stock.
According to data from MarketBeat, the company has an average rating of “Hold”
and an average target price of $240.00. Read more ...
Algonquin Power & Utilities (TSE:AQN) was downgraded by investment analysts at National Bank Financial from an "outperfrom under weight" rating to a "sector perform under weight" rating in a report issued on Tuesday. National Bank Financial also issued estimates for Algonquin Power & Utilities' Q1 2022 earnings at $0.27 EPS, Q4 2022 earnings at $0.26 EPS and FY2023 earnings at $0.95 EPS.
AQN has been the subject of a number of other reports. Royal
Bank of Canada restated an "outperform" rating and issued a C$18.00
target price on shares of Algonquin Power & Utilities in a research note on
Tuesday, January 4th. National Bankshares downgraded Algonquin Power &
Utilities to a "hold" rating in a research report on Wednesday. Four
research analysts have rated the stock with a hold rating, four have assigned a
buy rating and one has assigned a strong buy rating to the company's stock.
According to MarketBeat.com, the stock currently has a consensus rating of
"Buy" and an average price target of C$20.00. Read more ...
Atlantic Securities downgraded shares of Colgate-Palmolive (NYSE:CL) from an overweight rating to a neutral rating in a report published on Tuesday, Marketbeat Ratings reports. The firm currently has $80.00 price objective on the stock, down from their prior price objective of $92.00.
A number of other equities research analysts also recently
issued reports on CL. TheStreet upgraded shares of Colgate-Palmolive from a c+
rating to a b rating in a research note on Friday, April 29th. StockNews.com
downgraded shares of Colgate-Palmolive from a buy rating to a hold rating in a
research note on Wednesday, April 13th. Stifel Nicolaus reduced their price
target on shares of Colgate-Palmolive from $90.00 to $88.00 in a research note
on Wednesday, April 13th. JPMorgan Chase & Co. reduced their price target
on shares of Colgate-Palmolive from $86.00 to $81.00 and set a neutral rating
on the stock in a research note on Wednesday, March 30th. Finally, Wells Fargo
& Company reduced their price target on shares of Colgate-Palmolive from
$78.00 to $76.00 and set an underweight rating on the stock in a research note
on Monday, January 31st. Two investment analysts have rated the stock with a
sell rating, thirteen have issued a hold rating and three have assigned a buy
rating to the stock. Based on data from MarketBeat.com, the company has a
consensus rating of Hold and a consensus target price of $85.56. Read more ...
Consolidated Edison (NYSE:ED) was downgraded by equities research analysts at Wells Fargo & Company from an "equal weight" rating to a "sell" rating in a research note issued to investors on Tuesday, MarketBeat.com reports. They presently have a $94.00 price objective on the utilities provider's stock, up from their previous price objective of $85.00. Wells Fargo & Company's price objective would indicate a potential upside of 2.16% from the stock's previous close.
Several other equities research analysts also recently
issued reports on the stock. Guggenheim downgraded shares of Consolidated
Edison from a "neutral" rating to a "sell" rating and cut
their price objective for the stock from $77.00 to $71.00 in a research report
on Thursday, January 20th. Morgan Stanley raised their price objective on
shares of Consolidated Edison from $75.00 to $82.00 and gave the stock an
"underweight" rating in a research report on Wednesday, April 20th.
Wolfe Research upgraded shares of Consolidated Edison from an
"underperform" rating to a "peer perform" rating and set a
$82.00 price target for the company in a research report on Thursday, February
17th. KeyCorp lifted their price target on shares of Consolidated Edison from
$71.00 to $72.00 and gave the company an "underweight" rating in a
research report on Wednesday, April 20th. Finally, The Goldman Sachs Group
lifted their price target on shares of Consolidated Edison from $65.00 to
$83.00 and gave the company a "sell" rating in a research report on
Thursday, March 31st. Seven equities research analysts have rated the stock
with a sell rating, five have issued a hold rating and one has given a buy
rating to the company. According to data from MarketBeat.com, the company has a
consensus rating of "Hold" and a consensus price target of $82.83. Read more ...
Kellogg (NYSE:K) was downgraded by research analysts at Piper Sandler from a "neutral" rating to an "underweight" rating in a report issued on Tuesday, Briefing.com reports. They currently have a $62.00 target price on the stock, down from their prior target price of $66.00. Piper Sandler's price target suggests a potential downside of 7.97% from the company's current price.
Several other research firms have also issued reports on K.
StockNews.com initiated coverage on Kellogg in a research note on Thursday,
March 31st. They set a "hold" rating on the stock. BMO Capital
Markets lowered shares of Kellogg from an "outperform" rating to a
"market perform" rating and lowered their price objective for the
company from $75.00 to $70.00 in a research note on Monday, January 31st.
Deutsche Bank Aktiengesellschaft downgraded shares of Kellogg from a
"buy" rating to a "hold" rating and cut their target price
for the stock from $74.00 to $73.00 in a research note on Monday, April 25th.
Bank of America downgraded shares of Kellogg from a "buy" rating to a
"neutral" rating and dropped their price target for the stock from
$76.00 to $70.00 in a research note on Wednesday, January 5th. Finally, UBS
Group assumed coverage on Kellogg in a research report on Wednesday, March
30th. They set a "buy" rating and a $73.00 price objective on the
stock. Two investment analysts have rated the stock with a sell rating, nine
have given a hold rating and three have issued a buy rating to the stock. Based
on data from MarketBeat.com, the stock has an average rating of
"Hold" and an average target price of $66.80. Read more ...
Piper Sandler cut shares of Tyson Foods (NYSE:TSN) from a neutral rating to an underweight rating in a research note published on Tuesday morning, Marketbeat Ratings reports. They currently have $81.00 price target on the stock, down from their previous price target of $87.00.
TSN has been the topic of a number of other reports.
Stephens boosted their target price on Tyson Foods from $110.00 to $115.00 and
gave the stock an overweight rating in a research report on Tuesday, February
8th. JPMorgan Chase & Co. boosted their target price on Tyson Foods from
$88.00 to $91.00 and gave the company a neutral rating in a research note on
Tuesday, February 8th. Barclays downgraded Tyson Foods from an overweight
rating to an equal weight rating and boosted their target price for the company
from $95.00 to $100.00 in a research note on Monday, February 14th.
StockNews.com upgraded Tyson Foods from a buy rating to a strong-buy rating in
a research note on Friday, April 15th. Finally, Zacks Investment Research
downgraded Tyson Foods from a buy rating to a hold rating and set a $98.00
target price on the stock. in a research note on Monday, April 11th. One
equities research analyst has rated the stock with a sell rating, seven have
issued a hold rating and three have assigned a buy rating to the stock.
According to MarketBeat.com, Tyson Foods presently has a consensus rating of
Hold and an average price target of $97.33. Read more ...
Leggett & Platt (NYSE:LEG) was downgraded by equities research analysts at Raymond James from an "outperform" rating to a "market perform" rating in a note issued to investors on Wednesday, Briefing.com reports.
Several other equities research analysts also recently
issued reports on LEG. StockNews.com raised Leggett & Platt from a
"sell" rating to a "hold" rating in a research note on
Tuesday. Piper Sandler decreased their price target on shares of Leggett &
Platt from $43.00 to $38.00 and set a "neutral" rating for the
company in a report on Thursday, April 7th. Finally, TheStreet cut shares of
Leggett & Platt from a "b-" rating to a "c+" rating in
a report on Friday, March 11th. Three investment analysts have rated the stock
with a hold rating and one has given a buy rating to the company's stock.
According to MarketBeat, Leggett & Platt presently has an average rating of
"Hold" and an average target price of $46.00.
Shares of Leggett & Platt stock opened at $38.34 on
Wednesday. The company's 50-day moving average price is $36.35 and its
two-hundred day moving average price is $39.77. The stock has a market cap of
$5.13 billion, a PE ratio of 12.95, a price-to-earnings-growth ratio of 1.32
and a beta of 1.30. The company has a current ratio of 1.55, a quick ratio of
0.80 and a debt-to-equity ratio of 1.09. Leggett & Platt has a 52 week low
of $33.80 and a 52 week high of $59.16. Read more ...
AbbVie (NYSE:ABBV) was downgraded by investment analysts at Daiwa Capital Markets from an "outperform" rating to a "neutral" rating in a report released on Friday, The Fly reports.
ABBV has been the subject of a number of other research
reports. Wells Fargo & Company lifted their price objective on shares of
AbbVie from $165.00 to $200.00 in a research report on Monday. Bank of America
lifted their price objective on shares of AbbVie from $135.00 to $138.00 and
gave the company a "neutral" rating in a research report on Thursday,
February 3rd. BMO Capital Markets lifted their price objective on shares of
AbbVie from $161.00 to $174.00 and gave the company an "outperform"
rating in a research report on Monday, April 25th. Mizuho lifted their target
price on shares of AbbVie from $154.00 to $166.00 and gave the stock a
"buy" rating in a report on Friday, February 4th. Finally, JPMorgan
Chase & Co. lifted their target price on shares of AbbVie from $165.00 to
$180.00 in a report on Thursday, February 3rd. Five equities research analysts
have rated the stock with a hold rating, eleven have assigned a buy rating and
one has assigned a strong buy rating to the company's stock. Based on data from
MarketBeat, the stock presently has an average rating of "Buy" and a
consensus price target of $160.07. Read more ...
Black Hills (NYSE:BKH - Get Rating) was downgraded by equities researchers at Mizuho from a "buy" rating to a "neutral" rating in a research note issued on Friday, The Fly reports.
Separately, StockNews.com lowered Black Hills from a
"hold" rating to a "sell" rating in a research report on
Wednesday, April 27th. One equities research analyst has rated the stock with a
sell rating, two have given a hold rating and two have given a buy rating to
the stock. According to data from MarketBeat, the stock presently has a
consensus rating of "Hold" and a consensus price target of $75.00.
BKH stock opened at $75.34 on Friday. The company has a
current ratio of 0.90, a quick ratio of 0.73 and a debt-to-equity ratio of
1.43. Black Hills has a 12-month low of $61.95 and a 12-month high of $80.95.
The stock has a market cap of $4.88 billion, a price-to-earnings ratio of
18.69, a PEG ratio of 2.89 and a beta of 0.48. The business's 50-day moving
average is $74.71 and its 200 day moving average is $69.82. Read more ...
